Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jun;84(11):3565-9.
doi: 10.1073/pnas.84.11.3565.

Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan

Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan

H B Nader et al. Proc Natl Acad Sci U S A. 1987 Jun.

Abstract

The structure of the glycosaminoglycan chain of a heparan sulfate proteoglycan isolated from the conditioned medium of an endothelial cell line has been analyzed by using various degradative enzymes (heparitinase I, heparitinase II, heparinase, glycuronidase, sulfatases) from Flavobacterium heparinum. This proteoglycan inhibits the thromboplastin-activated pathway of coagulation; as a consequence, the catalytic conversion of prothrombin to thrombin is arrested. Heparitinase I (EC 4.2.2.8), an enzyme with specificity restricted to the heparan sulfate portion of the polysaccharide, releases fragments with the electrophoretic mobility and the structure of heparin. Conversely, an assessment of the size and distribution of the heparan sulfate regions has been provided by the use of heparinase (EC 4.2.2.7), which, by degrading the heparin sections of the chain, releases two segments that exhibit the structure of heparan sulfate. One of these segments is attached to the protein core. On the basis of these findings, the heparan sulfate chain can be defined as a copolymer containing heparin regions in its structure. The combined use of these enzymes has made it possible to establish the disaccharide sequence of parts of the glycosaminoglycan moiety of this proteoglycan.

PubMed Disclaimer

References

    1. Can J Physiol Pharmacol. 1968 May;46(3):351-60 - PubMed
    1. J Biol Chem. 1960 Nov;235:3283-6 - PubMed
    1. Biochemistry. 1971 Apr 13;10(8):1437-45 - PubMed
    1. J Biol Chem. 1973 Sep 25;248(18):6408-15 - PubMed
    1. Carbohydr Res. 1974 Oct;37(1):181-92 - PubMed

Publication types